HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Lussato Selected Research

Therapeutics

2/2006Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Lussato Research Topics

Disease

3Thyroid Neoplasms (Thyroid Cancer)
08/2006 - 06/2004
1Struma Ovarii
08/2006
1Hypothyroidism
02/2006
1Hematoma
06/2004

Drug/Important Bio-Agent (IBA)

2Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
02/2006 - 06/2004
1ThyroglobulinFDA Link
02/2006
1Thyrotropin AlfaFDA LinkGeneric
06/2004
1Thyroid HormonesIBA
06/2004
1AnticoagulantsIBA
06/2004

Therapy/Procedure

1Thyroidectomy
08/2006
1Therapeutics
02/2006
1Intramuscular Injections
06/2004